We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
No earnings data to show.
Consensus PT $11.74 · 5 analysts
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 01. 23. | Barclays | — | Upgrade | Equal-Weight → Overweight | — | Barclays: Equal-Weight → Overweight |
| 2025. 09. 16. | Barclays | — | Downgrade | Overweight → Equal-Weight | — | Barclays: Overweight → Equal-Weight |
| 2024. 09. 20. | Morgan Stanley | — | Maintain | Overweight → Overweight | — | Morgan Stanley: Overweight |
| 2024. 03. 27. | Argus Research | — | Maintain | Buy → Buy | — | Argus Research: Buy |
| 2023. 11. 01. | Morgan Stanley | — | Initiate coverage | — → Overweight | — | Morgan Stanley: Overweight |
| 2023. 04. 06. | Argus Research | — | Upgrade | Hold → Buy | — | Argus Research: Hold → Buy |